Joan Mannick
21Patents
7h-index
54Co-inventors
72Inventor score
Filing activity: Dec 12, 2002 → May 4, 2023
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9815901B2 | Treatment of cancer using a CD123 chimeric antigen receptor | Chemistry; Metallurgy | 80 | Active |
| US10174095B2 | Nucleic acid encoding a humanized anti-BCMA chimeric antigen receptor | Chemistry; Metallurgy | 27 | Active |
| US10287354B2 | Regulatable chimeric antigen receptor | Chemistry; Metallurgy | 21 | Active |
| US10004803B2 | Low, immune enhancing, dose mtor inhibitors and uses thereof | Chemistry; Metallurgy | 10 | Active |
| US10286069B2 | Low, immune enhancing, dose MTOR inhibitors and uses thereof | Chemistry; Metallurgy | 8 | Active |
| US11084880B2 | Anti-BCMA chimeric antigen receptor | Chemistry; Metallurgy | 8 | Active |
| US10357514B2 | Treatment of cancer using anti-CD19 Chimeric Antigen Receptor | Chemistry; Metallurgy | 7 | Active |
| US10441584B2 | Methods of enhancing immune response | Human Necessities | 2 | Active |
| US10568947B2 | Treatment of cancer using a CLL-1 chimeric antigen receptor | Chemistry; Metallurgy | 1 | Active |
| US10774388B2 | Biomarkers predictive of therapeutic responsiveness to chimeric antigen receptor therapy and uses thereof | Physics | 1 | Active |
| US10703819B2 | Treatment of cancer using a CD123 chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
| US11578130B2 | Regulatable chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
| US12214037B2 | Treatment of cancer using humanized anti-BCMA chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
| US10576076B2 | Pharmaceutical combination of everolimus with dactolisib | Human Necessities | 0 | Active |
| US10596165B2 | Combination therapies | Human Necessities | 0 | Active |
| US11459390B2 | Phosphoglycerate kinase 1 (PGK) promoters and methods of use for expressing chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
| US11591404B2 | Treatment of cancer using a CD123 chimeric antigen receptor | Chemistry; Metallurgy | 0 | Active |
| US12252518B2 | Methods of treating non-arteritic anterior ischemic optic neuropathy | Chemistry; Metallurgy | 0 | Active |
| US11045463B2 | Methods of enhancing immune response | Human Necessities | 0 | Active |
| US7419834B2 | System for detection of nitrosylated proteins | Emerging Cross-Sectional Technologies | 0 | Expired |
| US10993940B2 | Methods of enhancing immune response | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.